Category: Pharmacovigilance

Regulatory Toxicology Services for Medicinal Products: Ensuring Safety and Global Compliance Regulatory Toxicology Services for Medicinal Products are very important for the development, approval, and commercialization of pharmaceuticals and biologics. To ensure that a medicinal product is safe for human use before it comes to market, regulatory authorities in the world need a thorough toxicological… Continue reading Regulatory Toxicology Services for Medicinal Products: Ensuring Safety and Global Compliance

Toxicological Risk Assessment Services: Supporting Product Safety and Regulatory Compliance Pharmaceutical products, chemicals, medical devices, cosmetics and any other regulated products must be assessed for safety through Toxicological Risk Assessment Services.

Regulatory Medical Writing Services for Faster, Compliant Drug Approvals With today’s complex regulatory landscape for pharmaceutical and biotechnology products, proper documentation that is accurate and ready for submission is critical to product approval.

A Complete Guide to Toxicological Risk Assessment in the Pharma Industry The pharmaceutical industry is founded on one key promise – getting medicines to patients safely and effectively. All drugs before entering into clinical trials or commercial markets, will go through a thorough evaluation process called Toxicological Risk Assessment (TRA).

What is a Periodic Safety Update Report (PSUR)? In the pharmaceutical industry, monitoring the safety of medicines does not stop after a drug is approved and marketed. Continuous safety evaluation is essential to identify potential risks and ensure patient protection. A Periodic Safety Update Report (PSUR) is a key pharmacovigilance document that provides updated safety… Continue reading What is a Periodic Safety Update Report (PSUR)

What is a Periodic Benefit-Risk Evaluation Report (PBRER)? A Periodic Benefit-Risk Evaluation Report (PBRER) is a comprehensive pharmacovigilance document submitted by Marketing Authorization Holders (MAHs) to regulatory authorities to evaluate a medicine’s ongoing safety profile and its overall benefit-risk balance. The PBRER provides a structured analysis of new safety data collected during a defined reporting… Continue reading What is a Periodic Benefit-Risk Evaluation Report (PBRER)?

What Is a PADER? Understanding the Periodic Adverse Drug Experience Report Pharmacovigilance plays a critical role in ensuring patient safety throughout a product’s lifecycle. One of the key regulatory requirements in the United States is the Periodic Adverse Drug Experience Report (PADER). This report allows regulatory authorities to continuously evaluate the safety profile of approved… Continue reading What Is a PADER?

What is Eco-Pharmacovigilance? Eco-Pharmacovigilance (EPV) is the group of science and activity that is related to identifying, measuring, comprehending, and avoiding the negative impact of pharmaceutical substances on the environment. It is concerned with the detection of risks of medicinal products as soon as they get into the ecosystems either through human actions, through manufacturing… Continue reading What is Eco-Pharmacovigilance?

What Is Drug Safety? Drug safety or pharmacovigilance is the field and practice of identifying, evaluating, interpreting, and averting the negative effects or any other issues regarding drugs. Its main aim is to guarantee that drugs are safe in the lifecycle of their patient use that is, both in clinical development and in post-marketing use.

What is Risk Management in Pharma? Risk management in the pharmaceutical industry is a structured approach to identifying, assessing, and mitigating potential risks that may affect patient safety, product quality, or regulatory compliance.